De Novo Discovery of α,α-Disubstituted α-amino Acid-Containing α-helical Peptides as Competitive PPARγ PPI Inhibitors
Journal of the American Chemical Society · 19.11.2025 · 147 (46) · 42607-42617
DOI: 10.1021/jacs.5c13803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 04.11.2025. Verfasst von Maxwell Sigal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Hauptthemen laut MEDLINE: Amino Acids, Peptides, PPAR gamma, Drug Discovery. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
α,α-Disubstituted α-amino acids (dαAAs) are important building blocks for peptidomimetics as they are strong inducers of helicity and protect against proteolytic degradation. However, de novo discovery of dαAA-containing peptides with genetically encoded libraries is limited due to their poor incorporation efficiency. Here, we report the optimized ribosomal incorporation of multiple achiral dαAAs into peptide libraries and their application to high-throughput (>1012 members) affinity selection against the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARγ). This dαAA-based screening methodology discovered potent linear and macrocyclic α-helical peptides with low-to-sub nanomolar binding affinities. Hit peptides were proteolytically stable in serum and cell permeable, allowing for in cellulo antagonism of PPARγ. X-ray crystallography revealed that dαAA-containing peptides bound at the α-helical protein–protein interaction (PPI) interface via an α-helical conformation. This work validates the potential of a dαAA-based, α-helical discovery platform, providing access to new chemical and conformational space to de novo identify novel α-helical peptidomimetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
- Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich D-81377, Germany.
- Department of Biochemistry, Graduate School of Medicine, Yokohama City University, Kanazawa-ku, Yokohama 236-0004, Japan.
ORCID-Profile: Maxwell Sigal, Daniel Merk, Takayuki Katoh, Hiroaki Suga
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Sigal, M., Egner, M., Okada, C., Merk, D., Sengoku, T., Katoh, T., & Suga, H. (2025). De Novo Discovery of α,α-Disubstituted α-amino Acid-Containing α-helical Peptides as Competitive PPARγ PPI Inhibitors. Journal of the American Chemical Society, 147(46), 42607-42617. https://doi.org/10.1021/jacs.5c13803
Vancouver
Sigal M, Egner M, Okada C, Merk D, Sengoku T, Katoh T, et al. De Novo Discovery of α,α-Disubstituted α-amino Acid-Containing α-helical Peptides as Competitive PPARγ PPI Inhibitors. Journal of the American Chemical Society. 2025;147(46):42607-42617. doi:10.1021/jacs.5c13803
BibTeX
@article{Sigal2025,
author = {Sigal, Maxwell and Egner, Markus and Okada, Chikako and Merk, Daniel and Sengoku, Toru and Katoh, Takayuki and Suga, Hiroaki},
title = {De Novo Discovery of α,α-Disubstituted α-amino Acid-Containing α-helical Peptides as Competitive PPARγ PPI Inhibitors},
journal = {Journal of the American Chemical Society},
year = {2025},
volume = {147},
number = {46},
pages = {42607--42617},
doi = {10.1021/jacs.5c13803}
}
EUVIMED